Development Technologies Corp. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. The company was formerly known as Pegasus Pharmaceuticals Inc. and changed its name to Development Technologies Corp. in April 2022. Development Technologies Corp. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.
0 transactions — 0 buys and 0 sales reported by Development Technologies Corp. executives.
0 institutional funds report a position on DVTC in their latest SEC quarterly filing.
Beyond raw data, we aggregate and score every smart money signal to give you a unique view.
8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.
Detection of clustered purchases or sales by several executives in the same stock.
Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.
NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.
Spot marked changes in search interest around the stocks being followed.
Create your watchlist and receive a brief of events affecting your tickers.
This public page only shows a preview. The full analysis of DVTC on the Kairos Insider dashboard includes:
Free signup · Pro €19/month or €190/year